WHO Consults On Establishing Stability Of IVDs Under Pre-Qualification Program
This article was originally published in Clinica
The World Health Organization has developed a draft "technical guidance series" to help IVD manufacturers develop and gather data to support their claims regarding product stability. The final version of the document is expected to be published in early 2016.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.